D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
Biogen
BIIB
|
+$429M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$397M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$247M |
| 5 |
Union Pacific
UNP
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$632M |
| 2 |
Marathon Petroleum
MPC
|
+$474M |
| 3 |
Meta Platforms (Facebook)
META
|
+$469M |
| 4 |
DuPont de Nemours
DD
|
+$444M |
| 5 |
Phillips 66
PSX
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.1% |
| 2 | Communication Services | 8.89% |
| 3 | Technology | 8.48% |
| 4 | Energy | 7.71% |
| 5 | Financials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Insulet
PODD
$11.3B
| $20.3M | 0.03% |
537,638
+369,173
| +219% | +$12.4M |
|
627
Vulcan Materials
VMC
$36.3B
| $20.3M | 0.03% |
213,627
-239,130
| -53% | -$23.2M |
|
628
CALL
AbbVie
ABBV
$458B
| $20.2M | 0.03% |
341,300
+120,000
| +54% | +$6.91M |
|
629
Graphic Packaging
GPK
$3.26B
| $20.2M | 0.03% |
1,572,903
+934,434
| +146% | +$12.6M |
|
|
WMGI
630
DELISTED
Wright Medical Group Inc
WMGI
| $20.1M | 0.03% |
829,370
+428,423
| +107% | +$9.28M |
|
631
NXP Semiconductors
NXPI
$68B
| $20M | 0.03% |
237,164
-330,697
| -58% | -$28.3M |
|
632
PUT
Coca-Cola
KO
$354B
| $20M | 0.03% |
464,700
+335,000
| +258% | +$14.2M |
|
633
NextEra Energy
NEE
$187B
| $19.9M | 0.03% |
765,560
+1,604
| +0.2% | +$40.6K |
|
634
CALL
General Dynamics
GD
$105B
| $19.8M | 0.03% |
144,100
| – | – |
|
635
SL Green Realty
SLG
$3.88B
| $19.8M | 0.03% |
180,922
+177,173
| +4,726% | +$19.9M |
|
636
Stryker
SYK
$127B
| $19.7M | 0.03% |
212,345
+90,078
| +74% | +$8.62M |
|
637
Newell Brands
NWL
$2.16B
| $19.6M | 0.03% |
444,438
-153,145
| -26% | -$6.7M |
|
638
Teleflex
TFX
$5.85B
| $19.6M | 0.03% |
148,948
+3,475
| +2% | +$452K |
|
639
Gentex
GNTX
$4.88B
| $19.5M | 0.03% |
1,216,678
-5,970
| -0.5% | -$96.5K |
|
640
Lam Research
LRCX
$382B
| $19.5M | 0.03% |
2,451,480
+1,200,500
| +96% | +$9.03M |
|
|
ICPT
641
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $19.4M | 0.03% |
129,700
+40,700
| +46% | +$6.89M |
|
642
iShares Biotechnology ETF
IBB
$9.31B
| $19.4M | 0.03% |
+171,633
| New | +$18.6M |
|
643
PUT
Palo Alto Networks
PANW
$264B
| $19.1M | 0.03% |
652,200
+83,400
| +15% | +$2.41M |
|
644
PUT
Thermo Fisher Scientific
TMO
$211B
| $19.1M | 0.03% |
134,700
| – | – |
|
|
POT
645
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $19.1M | 0.03% |
1,113,700
+820,000
| +279% | +$16.3M |
|
646
Charles River Laboratories
CRL
$10.9B
| $19M | 0.03% |
236,819
+138,774
| +142% | +$10M |
|
647
CALL
Herbalife
HLF
$1.23B
| $19M | 0.03% |
710,000
+660,000
| +1,320% | +$18.3M |
|
648
PUT
PepsiCo
PEP
$186B
| $19M | 0.03% |
190,000
-18,300
| -9% | -$1.83M |
|
649
Pentair
PNR
$10.2B
| $19M | 0.03% |
570,430
-171,938
| -23% | -$6.29M |
|
650
PUT
Macy's
M
$6.15B
| $19M | 0.03% |
541,900
+434,900
| +406% | +$18.8M |
|
Similar funds
D.E. Shaw & Co's Q4 2015 Portfolio in Review
As of Q4 2015, D.E. Shaw & Co held 4,165 positions worth $67.2B, down 1.1% from $67.9B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
D.E. Shaw & Co withdrew a net $4.09B in Q4 2015, closing 409 positions and reducing 1,417 holdings. Its most notable exit was Altera Corp, an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.
Against the trend, D.E. Shaw & Co opened a new position in Alphabet (Google) Class A worth $417M.
- D.E. Shaw & Co's largest Q4 2015 buy was Alphabet (Google) Class A: 10,723,880 shares worth $417M.
- D.E. Shaw & Co added most to Apple in Q4 2015, an estimated $483M increase.
- D.E. Shaw & Co's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $632M.
- D.E. Shaw & Co fully exited Altera Corp in Q4 2015, selling an estimated $236M.
- D.E. Shaw & Co's ten largest holdings make up 8.8% of its $67.2B portfolio in Q4 2015.
- D.E. Shaw & Co opened 463 new positions and closed 409 in Q4 2015.
- D.E. Shaw & Co's portfolio value fell 1.1% quarter-over-quarter to $67.2B.
Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.